Gross Profit for Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's current gross profit (TTM) is $250.28B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
NVO
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$250.28B
YoY change
+1.8%
5Y CAGR
+18.7%
Peak year (2025)
$250.28B
Cumulative gross profit
$2.21T
Gross Profit history chart for Novo Nordisk (NVO) from 1985 to 2025
Gross Profit history table for Novo Nordisk (NVO) from 1985 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $250.28B | +1.8% | ||
| 2024 | $245.88B | +25.1% | ||
| 2023 | $196.50B | +32.3% | ||
| 2022 | $148.51B | +26.8% | ||
| 2021 | $117.14B | +10.5% | ||
| 2020 | $106.01B | +4.0% | ||
| 2019 | $101.93B | +8.2% | ||
| 2018 | $94.21B | +0.2% | ||
| 2017 | $94.06B | -0.6% | ||
| 2016 | $94.60B | +3.1% | ||
| 2015 | $91.74B | +23.6% | ||
| 2014 | $74.24B | +6.9% | ||
| 2013 | $69.43B | +7.5% | ||
| 2012 | $64.56B | +20.1% | ||
| 2011 | $53.76B | +9.5% | ||
| 2010 | $49.10B | +20.8% | ||
| 2009 | $40.64B | +14.4% | ||
| 2008 | $35.53B | +10.8% | ||
| 2007 | $32.09B | +10.0% | ||
| 2006 | $29.16B | +18.8% | ||
| 2005 | $24.55B | +16.2% | ||
| 2004 | $21.13B | +10.3% | ||
| 2003 | $19.15B | +3.4% | ||
| 2002 | $18.53B | +4.4% | ||
| 2001 | $17.75B | +8.0% | ||
| 2000 | $16.44B | +28.3% | ||
| 1999 | $12.81B | +22.8% | ||
| 1998 | $10.43B | -14.9% | ||
| 1997 | $12.26B | +14.2% | ||
| 1996 | $10.74B | +8.6% | ||
| 1995 | $9.88B | +2.1% | ||
| 1994 | $9.68B | +43.7% | ||
| 1993 | $6.74B | -17.3% | ||
| 1992 | $8.14B | +61.8% | ||
| 1991 | $5.03B | +19.7% | ||
| 1990 | $4.21B | +9.1% | ||
| 1989 | $3.85B | +32.3% | ||
| 1988 | $2.91B | +19.5% | ||
| 1987 | $2.44B | +172.8% | ||
| 1986 | $893.58M | -57.1% | ||
| 1985 | $2.09B | — |
Gross Profit values are taken from Novo Nordisk's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
Analysis
As of the 2025 fiscal year, Novo Nordisk (NVO) reported gross profit of $250.28B – edged up 1.8% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Novo Nordisk gross profit compounded at +18.7% per year, sustaining 8 straight years of year-over-year growth.
2025 marks the peak gross profit at $250.28B, with the historical low of $893.58M recorded in 1986.
Within Healthcare, Novo Nordisk (NVO) ranks 1st among 8 peers we track. The peer median for gross profit is $50.55B.
Novo Nordisk Gross Profit by Year
Novo Nordisk Gross Profit 2025: $250.28B
Novo Nordisk gross profit in 2025 was $250.28B, edged up 1.8% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk Gross Profit 2024: $245.88B
Novo Nordisk gross profit in 2024 was $245.88B, grew 25.1% from 2023.
Novo Nordisk Gross Profit 2023: $196.50B
Novo Nordisk gross profit in 2023 was $196.50B, surged 32.3% from 2022.
Novo Nordisk Gross Profit 2022: $148.51B
Novo Nordisk gross profit in 2022 was $148.51B, grew 26.8% from 2021.
Novo Nordisk Gross Profit 2021: $117.14B
Novo Nordisk gross profit in 2021 was $117.14B.
See more financial history for Novo Nordisk (NVO).
Sector peers — Gross Profit
Companies in the same sector as Novo Nordisk, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $16.78B | Healthcare |
Frequently asked questions
What is Novo Nordisk's gross profit?
- Latest reported gross profit for Novo Nordisk (NVO) is $250.28B (period ending December 31, 2025).
How has Novo Nordisk gross profit changed year-over-year?
- Novo Nordisk (NVO) gross profit changed +1.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Novo Nordisk gross profit?
- Novo Nordisk (NVO) gross profit compound annual growth rate is +18.7% over the most recent 5 years available.
When did Novo Nordisk gross profit hit its highest annual value?
- Novo Nordisk gross profit reached its highest annual value of $250.28B in 2025.
What was Novo Nordisk gross profit in 2024?
- Novo Nordisk (NVO) gross profit in 2024 was $245.88B.
What was Novo Nordisk gross profit in 2025?
- Novo Nordisk (NVO) gross profit in 2025 was $250.28B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
NVO Overview
Company profile, financial tools, and key metrics
NVO Revenue Counter
Earns 9,800 DKK every second. See per minute, hour, and day.
NVO Earnings Counter
Earns 3,248 DKK per second net profit. See per minute, hour, and day.
NVO What If Invested
What if you had invested $1,000? See historical returns from any date.
NVO How It Makes Money
Discover visual breakdown of 309.06B DKK in revenue — where it comes from and where it goes.
NVO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
NVO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
NVO Daily Price Character
Balanced · 47.3% historical win rate (green days). Streaks & record days.
NVO Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
NVO Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
NVO Dividend Profile
Yield: 4.62%. Safety: 5/8. See full history.
NVO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
NVO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.